Medexus Pharmaceuticals reported a strong performance in its Q3 FY2025 earnings call, with notable revenue growth and strategic advancements. The company highlighted a year-over-year increase in ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get ...

Trading options requires answering these questions: Which direction will a stock move, how far will it go and when will it happen? Here are 4 steps to get started. Many, or all, of the products ...

Welcome to McKesson's third quarter fiscal 2025 earnings conference call. Please be advised that today's conference is being ...

There’s perhaps no bigger or more important stock left on the earnings docket this quarter than Amazon (NASDAQ:AMZN), which ...

Merck & Co.'s heavy reliance on its cancer drug Keytruda, which accounts for nearly half of the company's revenue, is raising investor concerns as the drug's patent expiration approaches in 2028, The ...

New research highlights the significant health care resource utilization burden of generalized pustular psoriasis (GPP), ...

New York would become the first state to force pharmacy benefit managers to publicly reveal how much they profit from rebates issued by drug ...

We recently compiled a list of the Jim Cramer Recently Talked About These 11 S&P 500 Stocks. In this article, we are going to ...

President Donald Trump's threat of tariffs on goods from Mexico, Canada and China is aimed at stopping the flow of fentanyl ...

We recently published an article titled Jim Cramer’s Game Plan: 15 Stocks in Focus. In this article, we are going to take a ...

The female pilot killed in the Army helicopter collision with a passenger jet in Washington DC has been named as a former ...